Insider’s View: Deciphering Jaguar Health Inc (JAGX)’s Financial Health Through Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Jaguar Health Inc (NASDAQ: JAGX) closed at $0.29 in the last session, down -0.62% from day before closing price of $0.29. In other words, the price has decreased by -$0.62 from its previous closing price. On the day, 24.05 million shares were traded. JAGX stock price reached its highest trading level at $0.2939 during the session, while it also had its lowest trading level at $0.2651.

Ratios:

We take a closer look at JAGX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 7.48 whereas as Long-Term Debt/Eq ratio is at 6.43.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.

On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAGX now has a Market Capitalization of 83381128 and an Enterprise Value of 110746584. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.54 while its Price-to-Book (P/B) ratio in mrq is 4.28. Its current Enterprise Value per Revenue stands at 11.346 whereas that against EBITDA is -3.471.

Stock Price History:

Over the past 52 weeks, JAGX has reached a high of $1.22, while it has fallen to a 52-week low of $0.05. The 50-Day Moving Average of the stock is 109.78%, while the 200-Day Moving Average is calculated to be 19.60%.

Shares Statistics:

According to the various share statistics, JAGX traded on average about 69.86M shares per day over the past 3-months and 70749480 shares per day over the past 10 days. A total of 287.22M shares are outstanding, with a floating share count of 273.16M. Insiders hold about 4.90% of the company’s shares, while institutions hold 1.63% stake in the company. Shares short for JAGX as of 1714435200 were 14333632 with a Short Ratio of 0.21, compared to 1711584000 on 19706188. Therefore, it implies a Short% of Shares Outstanding of 14333632 and a Short% of Float of 4.99.

Most Popular